ADIPONEXIN
DEAD

Serial Number

97791583

Owner

Realize Therapeutics Corporation

Filing Date

Feb 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ADIPONEXIN Trademark

Serial Number: 97791583

ADIPONEXIN is a trademark filed by Realize Therapeutics Corporation on February 13, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently no longer active.

Owner Contact Info

Realize Therapeutics Corporation (12 trademarks)

37 Sherwood Terrace, Suite 109-110
Lake Bluff, IL 60044

Entity Type: 03

Trademark Details

Filing Date

February 13, 2023

Registration Date

Not Registered

Goods & Services

Dietary supplements; Food supplements; Nutritional supplements; Nutritional supplements in capsule form for dogs; Nutritional supplements, namely, probiotic compositions; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed additives for use as nutritional supplements for affecting, modulating, and improving body weight, waist circumference, body composition, body mass index, lean body mass, and related biochemistry and metabolism.; Dietary food supplements; Dietary and nutritional supplements; Dietary and nutritional supplements for affecting, modulating, and improving body weight, waist circumference, body composition, body mass index, lean body mass, and related biochemistry and metabolism.; Dietary and nutritional supplements used for weight loss; Dietary supplements in the nature of weight loss powders; Dietetic foods and beverages adapted for medical use; Dieting pills and powder preparations to promote fat burning; Health food supplements; Ketogenic dietary and nutritional supplements used for weight loss; Nutritional food additives for medical purposes in the nature of natural food extracts derived from affecting, modulating, and improving body weight, waist circumference, body composition, body mass index, lean body mass, and related biochemistry and metabolism.; Pharmaceutical agents affecting metabolism; Powdered nutritional supplement concentrate; Vitamins and dietary food supplements for animals

Weight loss program kits consisting primarily of printed instructions, pamphlets, labels, and diagrams on weight loss and dieting, and also including vitamin supplements and hormones; Printed instructional and teaching materials in the field of affecting, modulating, and improving body weight, waist circumference, body composition, body mass index, lean body mass, and related biochemistry and metabolism

Weight management services, namely, providing weight loss and/or weight maintenance programs; Consulting to individuals and communities engaged in group weight loss programs; Providing weight loss program services; Providing a website featuring information and advice in the fields of diet, weight loss, diet planning and lifestyle wellness; Providing information in the fields of diet and weight loss via a website; Providing medical information in the field of affecting, modulating, and improving body weight, waist circumference, body composition, body mass index, lean body mass, and related biochemistry and metabolism.; Providing wellness services, namely, weight loss programs offered at a wellness center

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 6, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 6, 2025 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 21, 2024 GNFN
FINAL REFUSAL E-MAILED
Aug 21, 2024 GNFR
FINAL REFUSAL WRITTEN
Aug 21, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 20, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 20, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 20, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 20, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 17, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 17, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 16, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 16, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 17, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 17, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 17, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 13, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 2, 2023 NWOS
NEW APPLICATION ENTERED
Feb 16, 2023 NWAP